Xiaming Zhu
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Oncology top 5%
- CAR-T cell therapy research
Papers in
- Oncology 26
- CAR-T cell therapy research 15
- Cancer survivorship and care 4
- Hematology 18
- Acute Myeloid Leukemia Research 13
- Hematopoietic Stem Cell Transplantation 9
- Chronic Myeloid Leukemia Treatments 4
- Multiple Myeloma Research and Treatments 4
- Co-authors
- Xiaowen Tang (24 shared papers)Depei Wu (20 shared papers)Haiping Dai (18 shared papers)Mingqing Zhu (5 shared papers)Jia Yin (13 shared papers)Guanghua Chen (2 shared papers)Ting Xu (4 shared papers)Zheng Li (2 shared papers)
- Journals
- Blood (9 papers)Frontiers in Oncology (3 papers)Cancer Nursing (2 papers)Cancer Medicine (2 papers)Bone Marrow Transplantation (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Xiaming Zhu
36 papers receiving 671 citations
Xiaming Zhu's Hit Papers
Peers
Comparison fields: 5 of 54
- Hematology 224
- Oncology 490
- Immunology 343
- Public Health, Environmental and Occupational Health 94
- Genetics 88
Countries citing papers authored by Xiaming Zhu
This map shows the geographic impact of Xiaming Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaming Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaming Zhu more than expected).
Fields of papers citing papers by Xiaming Zhu
This network shows the impact of papers produced by Xiaming Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaming Zhu. The network helps show where Xiaming Zhu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaming Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia. Hit paper breakdown → | 2018 | 356 |
| 2 | 2014 | 45 | |
| 3 | 2020 | 44 | |
| 4 | Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatment. | 2022 | 29 |
| 5 | 2017 | 20 | |
| 6 | 2021 | 18 | |
| 7 | 2018 | 15 | |
| 8 | 2019 | 12 | |
| 9 | 2018 | 12 | |
| 10 | 2020 | 11 | |
| 11 | 2018 | 10 | |
| 12 | 2018 | 9 | |
| 13 | 2020 | 9 | |
| 14 | 2014 | 9 | |
| 15 | In vitro expansion of murine hematopoietic progenitor cells by leukemia inhibitory factor, stem cell factor, and interleukin-1 beta. | 1996 | 8 |
| 16 | 2015 | 7 | |
| 17 | 2021 | 7 | |
| 18 | 2019 | 7 | |
| 19 | 2022 | 6 | |
| 20 | 2013 | 6 |
About Xiaming Zhu
Xiaming Zhu is a scholar working on Oncology, Hematology, Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 42 papers that have together received 677 indexed citations. Recurring topics across this work include CAR-T cell therapy research (15 papers), Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (10 papers), Hematopoietic Stem Cell Transplantation (9 papers), Chronic Myeloid Leukemia Treatments (4 papers), Cancer survivorship and care (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Hematology (224 citations), Oncology (490 citations), Immunology (343 citations), Public Health, Environmental and Occupational Health (94 citations) and Genetics (88 citations). Xiaming Zhu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xiaowen Tang, Depei Wu, Haiping Dai, Mingqing Zhu, Jia Yin, Guanghua Chen, Ting Xu, Zheng Li, Ansel P. Nalin and Fengtao You. Their work appears in journals such as Blood, Frontiers in Oncology, Cancer Nursing, Cancer Medicine and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.